Vertex Pharmaceuticals (VRTX)

EBITDA Margin

43.45%

Quarterly · Period ending:

VRTX logo

VRTX EBITDA Margin

Latest reported43.45%
VRTX Quarterly EBITDA Margin (100.00% → 43.45%)
High-resolution chart · PNG

VRTX ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals EBITDA Margin — Quarterly
Period endingEBITDA Margin
43.4536%
43.818%
43.0727%
44.0807%
45.1445%
28.2218%
40.6731%
46.3509%
-125.7673%
49.9777%
48.3457%
49.6155%
48.6965%
39.6539%
48.9339%
52.5554%
49.0074%
47.9428%
44.3806%
56.9354%
0.145%
50.1925%
57.3937%
51.1203%
56.7626%
46.1018%
50.7658%
11.6927%
39.2729%
42.1899%
6.447%
20.8845%
32.5405%
37.7781%
21.7025%
-67.173%
11.9566%
39.8966%
12.251%
-1.0452%
3.9612%
0.6963%
-9.4864%
-17.8119%
-93.3133%
-114.7175%
-97.5961%
-72.2019%
-130.6413%
-168.6799%
-117.157%
-49.3081%
-14.9335%
-130.5803%
-19.4342%
2.4458%
-0.3612%
22.9222%
41.3525%
32.6789%
-144.9783%
-210.7423%
-307.4614%
-838.7813%
-536.2501%
-677.3285%
-381.1827%
-563.5453%
-777.9847%
-675.1449%
-401.2282%
-385.3017%
-118.3463%
-217.4157%
-164.7729%
-258.6385%
-308.5716%
-112.27%
-28.6799%
-102.7942%
-242.1113%
-117.0184%
-20.5581%
-93.5952%
-119.4146%
-117.6187%
-50.3452%
-99.9702%
-178.5934%
-157.6258%
-964.2965%
-464.5325%
-463.9565%
84.9485%
-60.2206%
-85.4213%
-41.9206%
-51.0652%
-14.4377%
-34.0468%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.